These benefits, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two help the concept of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Ailments. A study review released in https://michaele591cge6.blog2news.com/profile